[MOL] Low=Dose 5-1z12; trials for myelodysplastic syn, phase 11 for elde [00082] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Low=Dose 5-1z12; trials for myelodysplastic syn, phase 11 for elderly patients....



Low-Dose 5-Aza-2'-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter
>Phase II Study in Elderly Patients
>
> http://www.jco.org/cgi/content/abstract/18/5/956
>
>PURPOSE: 5-Aza-2'-deoxycytidine (decitabine; DAC) is a DNA hypomethylating agent that has shown a 50% response rate in a small phase
>II study in elderly patients with high-risk myelodysplastic syndrome. We performed a second, multicenter phase II study in a larger
>group of patients to confirm our findings and to study the toxicity of DAC
>
>
>
Warmly, lillian
 
We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html
 
  ( Very informational, good tips, Molers pictures, art work and much more....